How HCP Insights Helped Uncover Adoption Barriers in Head & Neck Cancer

Business Problem

The client wanted to understand how radiation oncologists viewed an upcoming treatment for head and neck cancer. This included their perceptions of its efficacy and safety, potential barriers to prescribing, and likelihood of using the treatment once it became available.

What and How we did it

Borderless Access engaged with 50 radiation oncologists across the USA, Germany, France, and Italy through in-depth research discussions. The study explored physicians’ perceptions of the upcoming treatment, the factors that could influence its future use, and their likelihood of prescribing it once available.

Key Insights

  • Prescribing intent indicated high potential
    Half of the physicians surveyed said they would definitely prescribe the upcoming treatment, while another 30% said they would probably prescribe it. Together, these responses indicated a strong level of stated prescribing intent among the physicians surveyed.
  • Positive perceptions of efficacy and safety supported future uptake
    The upcoming treatment received positive perceptions around efficacy and safety, indicating that these attributes could support its potential use among radiation oncologists.
  • Understanding prescribing barriers remained important
    Alongside prescribing intent, the research examined the challenges and top barriers that could influence physicians’ willingness to prescribe the upcoming treatment. This helped the client look beyond initial interest and understand factors that could shape its future use.

Client Impact :

The findings helped the client assess the market potential for the upcoming treatment, identify gaps and opportunities, and support strategic planning and resource allocation around patient care and treatment outcomes.

Market

USA Flag

US

Germany Flag

Germany

France Flag

France

Italy Flag

Italy